RECENT NEWS

More than 100,000 patients have been treated in NHS virtual wards in the last year, with 16,000 patients treated in January alone. Virtual wards allow patients to get hospital-level care at home safely and in familiar surroundings, helping speed up their recovery while freeing up hospital beds for patients that need them most.

Tens of thousands of patients across the country could benefit from quicker, earlier diagnoses and more effective treatments for a range of conditions, as the Government invests nearly £16 million into pioneering artificial intelligence (AI) research.

The ABHI UK Pavilion at Arab Health 2023 saw its most vibrant and successful year to date, with organisers confirming record attendance.

Microorganisms live in or on almost every part of the human body and play an important role in the regulation of normal human processes. As a result, changes in the number or type of microorganisms, also known as the microbiome, can contribute to disease and altered responses to therapy, including cancer treatment.

A population data linkage study using anonymised primary and secondary care health records in Swansea University’s SAIL Databank has revealed that in 2020 and 2021, fewer people in Wales were diagnosed with long-term conditions than expected.

Contracting a lower respiratory tract infection in early childhood is associated with a higher risk of dying from respiratory disease as an adult, according to new research.

Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according to a review published in European Heart Journal – Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC). The paper highlights the biological, clinical and societal reasons why the condition may be missed in women, who respond less well to treatment and have worse clinical outcomes.

Analysis by the Independent Healthcare Providers Network (IHPN) has shown that for the first time, nine out of 10 independent hospitals have ‘Good’ or ‘Outstanding’ overall ratings from the health and care regulator, the Care Quality Commission (CQC).

NHS Blood and Transplant (NHSBT) has opened a state-of-the-art facility which will contribute greatly to the UK’s ability to develop and manufacture new gene and cell therapies.

People across England stand to benefit from a project to identify radical new approaches to prevent cardiovascular disease and reduce pressure on the NHS, following the appointment of Professor John Deanfield as Government Champion for Personalised Prevention.

Women across England will benefit from tailored healthcare and support by new women’s health hubs - improving access and quality of care for services for menstrual problems, contraception, pelvic pain, menopause care and more.

Less than two thirds of staff in the NHS would be happy with the standard of care in their organisation if a friend or relative needed treatment, according to the national NHS staff survey 2022. The proportion who would recommend their organisation as a place to work is also declining, and almost one in three staff “often think about leaving”.

A team from Guy’s and St Thomas’ have become the first in the world to operate through a patient’s mouth using the Versius robotic surgery system.

GPs and pharmacists have helped cut opioid prescriptions in England by 450,000 in under four years, latest data shows, as the NHS unveils a new action plan to crack down on the overuse of potentially-addictive medicines.

Artificial intelligence (AI) that predicts likely missed appointments and offers back-up bookings will be piloted by the NHS in a bid to maximise resources and potentially save billions.

A new Rare Diseases Action Plan for England has been published that will ensure those living with these conditions receive better care and treatment, fairer access to testing and have continued support.

An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.

In a new report, the Public Accounts Committee has warned that cancer waiting times are at their worst recorded level and NHS England will not meet its first cancer recovery target.

Applications for innovative proposals to harness canSERV's unified oncology services are now being invited. A first of its kind, the largest European-wide consortium of research infrastructures is offering free-of-charge transnational access to cutting-edge services to develop breakthrough personalised cancer treatments.

Althea UK and Medipass Healthcare – two of the UK’s leading Managed Equipment Services (MES) companies – have announced they have merged operations and have been rebranded as Ergéa.